Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 3”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02933372
What this trial is testing

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3

Who this might be right for
Parkinson's Disease
University of Michigan 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,854
Large-scale testing (Phase 3)Study completedNCT03358472
What this trial is testing

Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

Who this might be right for
Head and Neck Cancer
Incyte Corporation 89
Not applicableStudy completedNCT03079037
What this trial is testing

Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3

Who this might be right for
Parkinson Disease
University of Minnesota 15
Large-scale testing (Phase 3)Study completedNCT04003636
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 1,069
Large-scale testing (Phase 3)Study completedNCT00955318
What this trial is testing

Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 58
Testing effectiveness (Phase 2)Study completedNCT06036836
What this trial is testing

Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

Who this might be right for
Solid TumorCutaneous Squamous Cell CarcinomaEndometrial Cancer
Merck Sharp & Dohme LLC 163
Not applicableStudy completedNCT01228851
What this trial is testing

Balance Training in Parkinson's Disease Using the Wii Balance Board

Who this might be right for
Parkinson's Disease
Shirley Ryan AbilityLab 10
Early research (Phase 1)Study completedNCT03820037
What this trial is testing

Relative Bioavailability and Bioequivalence of Opicapone

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 45
Not applicableStudy completedNCT05126862
What this trial is testing

Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)

Who this might be right for
Huntington DiseaseParkinson Disease
University of Virginia 43
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Large-scale testing (Phase 3)Study completedNCT01058291
What this trial is testing

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 31
Not applicableNot Yet RecruitingNCT07832461
What this trial is testing

ANCILLARY STUDY No. 3 NS-PARK-OMICS

Who this might be right for
PARKINSON DISEASE (Disorder)
Institut National de la Santé Et de la Recherche Médicale, France 80
Not applicableStudy completedNCT06892418
What this trial is testing

Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study

Who this might be right for
Parkinson's DiseaseParkinson
Istanbul Medipol University Hospital 40
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)Study completedNCT01628926
What this trial is testing

A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 420
Large-scale testing (Phase 3)Study completedNCT04193527
What this trial is testing

Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Who this might be right for
Parkinsonian SyndromeParkinson Disease(PD)Multiple System Atrophy (MSA)+2 more
GE Healthcare 172
Large-scale testing (Phase 3)Looking for participantsNCT06345729
What this trial is testing

Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 600
Large-scale testing (Phase 3)Study completedNCT00957203
What this trial is testing

Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 308
Early research (Phase 1)Study completedNCT02778594
What this trial is testing

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 17
Next Page